Authors:
Inge K. Holden, Inge K. Holden, Claus Bistrup, Claus Bistrup, Anna Nilsson, Anna Nilsson, Janne Fuglsang Hansen, Janne Fuglsang Hansen, Rozeta Abazi, Rozeta Abazi, Jesper Rømhild Davidsen, Jesper Rømhild Davidsen, Mikael Kjær Poulsen, Susan Olaf L (...)
Inge K. Holden, Inge K. Holden, Claus Bistrup, Claus Bistrup, Anna Nilsson, Anna Nilsson, Janne Fuglsang Hansen, Janne Fuglsang Hansen, Rozeta Abazi, Rozeta Abazi, Jesper Rømhild Davidsen, Jesper Rømhild Davidsen, Mikael Kjær Poulsen, Susan Olaf Lindvig, Ulrik Stenz Justesen, Ulrik Stenz Justesen, Isik Somuncu Johansen, Isik Somuncu Johansen
(Read More)
Abstract:
Background It is currently not well described if a two-dose regimen of a Covid-19 vaccine is sufficient to elicit an immune response in SOT recipients. Results A total of 80 solid organ transplant (SOT) recipients completed a two-dose regimen with SARS-CoV-2 messenger RNA vaccine. Only 35.0% (n = 28) were able to mount a positive IgG immune response six weeks after the second dose of vaccine. Conclusion This emphasizes that SOT recipients need continued use of personal protective measures. Future studies need to closely examine the cellula (...)
Background It is currently not well described if a two-dose regimen of a Covid-19 vaccine is sufficient to elicit an immune response in SOT recipients. Results A total of 80 solid organ transplant (SOT) recipients completed a two-dose regimen with SARS-CoV-2 messenger RNA vaccine. Only 35.0% (n = 28) were able to mount a positive IgG immune response six weeks after the second dose of vaccine. Conclusion This emphasizes that SOT recipients need continued use of personal protective measures. Future studies need to closely examine the cellular immune response in patients with compromised antibody response to Covid-19 vaccination. This article is protected by copyright. All rights reserved.
(Read More)